Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Veradigm Inc.
  6. News
  7. Summary
    MDRX   US01988P1084

VERADIGM INC.

(MDRX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
17.75 USD   -1.77%
01/11Transcript : Veradigm Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:45 PM
CI
01/11Veradigm Approves Share Buyback Plan of Up to $250 Million, Provides Fiscal 2023 Guidance
MT
01/11Veradigm Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Point of Care Marketing Association

11/22/2022 | 04:02pm EST

Veradigm senior leadership to join board of directors

Veradigm, a business unit of Allscripts (NASDAQ: MDRX), announced today The Point of Care Marketing Association (POCMA), a nonprofit organization to support the continued growth of the Point of Care (POC) channel through education and advocacy, has welcomed Veradigm to its membership:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221122005809/en/

  • Veradigm Digital Health Media is the first EHR marketing solution to be accepted as a member of POCMA
  • Stuart Green, Senior Vice President & General Manager, Veradigm has joined POCMA’s board of directors

POCMA exists to advocate for the effective use of the point of care communication channel to advance patient healthcare outcomes. Members of the nonprofit point of care industry association work closely with brand, agency, and provider stakeholders to advocate for the channel and promote its positive impact to ensure its continued growth as a vital and innovative segment of healthcare marketing.

“POCMA is excited to have Veradigm as a member and the first within the EHR landscape,” said POCMA Executive Director, Nicole Divinagracia. “Veradigm’s platform of reaching HCPs in their workflow makes them an excellent resource for the association and its members. We look forward to their insights and involvement as we grow the POC industry.”

“At Veradigm, we share in POCMA’s goal of raising healthcare providers’ awareness through innovative point of care marketing channels,” said Stuart Green, Senior Vice President & General Manager, Veradigm. “With our membership, we look forward to contributing to the establishment of industry best practices and building connections with other point-of-care industry leaders and influencers.”

About Allscripts

Allscripts (Nasdaq: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, LinkedIn, and It Takes A Community: The Allscripts Blog.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Veradigm does it all. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.


ę Business Wire 2022
All news about VERADIGM INC.
01/11Transcript : Veradigm Inc. Presents at 41st Annual J.P. Morgan Healthcare Con..
CI
01/11Veradigm Approves Share Buyback Plan of Up to $250 Million, Provides Fiscal 2023 Guidan..
MT
01/11Veradigm Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
01/11Tranche Update on Veradigm Inc.'s Equity Buyback Plan announced on January 24, 2022.
CI
01/11Veradigm Inc. announces an Equity Buyback for $250 million worth of its shares.
CI
01/11Veradigm Announces New Share Repurchase Program and Initial Financial Guidance for Fisc..
BU
01/11Veradigm Inc. Provides Earnings Guidance for the Fiscal Year 2023
CI
01/11Veradigm Inc. s Equity Buyback announced on January 24, 2022 has expired.
CI
01/11Veradigm Inc. authorizes a Buyback Plan.
CI
01/10Veradigm Building Momentum Across All Markets
BU
More news
Analyst Recommendations on VERADIGM INC.
More recommendations
Financials (USD)
Sales 2022 615 M - -
Net income 2022 -0,65 M - -
Net Debt 2022 - - -
P/E ratio 2022 -645x
Yield 2022 -
Capitalization 1 939 M 1 939 M -
Capi. / Sales 2022 3,15x
Capi. / Sales 2023 2,96x
Nbr of Employees 8 000
Free-Float 38,1%
Chart VERADIGM INC.
Duration : Period :
Veradigm Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VERADIGM INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 17,75 $
Average target price 21,86 $
Spread / Average Target 23,1%
EPS Revisions
Managers and Directors
Richard J. Poulton Chief Executive Officer & Director
Thomas Langan President
Leah Jones Vice President-Finance & Sales Support
Joseph R. Rostock Chief Technology Officer & SVP-Product Engineering
Tejal Vakharia Chief Compliance Counsel & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
VERADIGM INC.0.62%1 939
VEEVA SYSTEMS INC.6.24%26 693
PRO MEDICUS LIMITED17.81%4 832
EVOLENT HEALTH, INC.11.36%3 116
SECTRA AB (PUBL)3.29%2 869
OMNICELL, INC.10.67%2 569